New drugs are costing more

Analysis from the drug research firm Brooklyn, found the average launch prices for new brand-name drugs have skyrocketed over the past decade. Why does it matter? The U.S. prescription drug market increasingly has thrived on high initial price tags and subsequent increases which has resulted in higher premiums and out-of-pocket costs for new drugs, as well as more expensive generics. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.